[PDF][PDF] Quality improvement guidelines for transarterial chemoembolization and embolization of hepatic malignancy
T Chemoembolization - Journal of vascular and interventional radiology …, 2017 - servei.org
An in-depth literature search is performed using electronic medical literature databases.
Then a critical review of peer-reviewed articles is performed with regard to the study …
Then a critical review of peer-reviewed articles is performed with regard to the study …
The progress in the treatment of hepatocellular carcinoma with portal vein tumor thrombus
F Luo, M Li, J Ding, S Zheng - Frontiers in Oncology, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is one of most prevalent cancer and is a serious healthcare
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …
Sorafenib plus hepatic arterial infusion chemotherapy versus sorafenib for hepatocellular carcinoma with major portal vein tumor thrombosis: a randomized trial
K Zheng, X Zhu, S Fu, G Cao, WQ Li, L Xu, H Chen… - Radiology, 2022 - pubs.rsna.org
Background The prognosis of hepatocellular carcinoma (HCC) with major portal vein tumor
thrombosis (PVTT) is dismal after standard treatment with sorafenib. Hepatic arterial infusion …
thrombosis (PVTT) is dismal after standard treatment with sorafenib. Hepatic arterial infusion …
Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international …
R Salem, SA Padia, M Lam, C Chiesa, P Haste… - European Journal of …, 2023 - Springer
Purpose In light of recently published clinical reports and trials, the TheraSphere Global
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …
Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group
R Salem, SA Padia, M Lam, J Bell, C Chiesa… - European journal of …, 2019 - Springer
Abstract The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by
BTG International to review existing data and address gaps in knowledge related to …
BTG International to review existing data and address gaps in knowledge related to …
Segmental Yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective …
SA Padia, GE Johnson, KJ Horton, CR Ingraham… - Journal of Vascular and …, 2017 - Elsevier
Purpose To compare segmental radioembolization with segmental chemoembolization for
localized, unresectable hepatocellular carcinoma (HCC) not amenable to ablation. Materials …
localized, unresectable hepatocellular carcinoma (HCC) not amenable to ablation. Materials …
Treatments of hepatocellular carcinoma with portal vein tumor thrombus: current status and controversy
ZJ Deng, L Li, YX Teng, YQ Zhang… - Journal of Clinical …, 2021 - pmc.ncbi.nlm.nih.gov
The proportions of patients with hepatocellular carcinoma (HCC) involving portal vein tumor
thrombus (PVTT) varies greatly in different countries or regions, ranging from 13% to 45 …
thrombus (PVTT) varies greatly in different countries or regions, ranging from 13% to 45 …
[HTML][HTML] Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges
JF Jiang, YC Lao, BH Yuan, J Yin, X Liu, L Chen… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Portal vein tumor thrombus is a frequent, challenging complication in hepatocellular
carcinoma. Hepatocellular carcinoma patients with portal vein tumor thrombus may show …
carcinoma. Hepatocellular carcinoma patients with portal vein tumor thrombus may show …
Recent advances in medical management of hepatocellular carcinoma
K Ikeda - Hepatology Research, 2019 - Wiley Online Library
Transcatheter arterial therapies for hepatocellular carcinoma (HCC) have developed during
the last decade. A fine powder formulation of cisplatin and the new platinum agent miriplatin …
the last decade. A fine powder formulation of cisplatin and the new platinum agent miriplatin …
Lenvatinib with or without concurrent drug-eluting beads transarterial chemoembolization in patients with unresectable, advanced hepatocellular carcinoma: a real …
D **a, W Bai, E Wang, J Li, X Chen, Z Wang, M Huang… - Liver cancer, 2022 - karger.com
Introduction: Lenvatinib is the first-line treatment for advanced hepatocellular carcinoma
(HCC). We aimed to compare the clinical outcomes of lenvatinib plus drug-eluting beads …
(HCC). We aimed to compare the clinical outcomes of lenvatinib plus drug-eluting beads …